Evidence map›Paper›PMID 34997335›Full record

ArticleArchives of microbiology2022

Acid tolerant bacterium Bacillus amyloliquefaciens MBNC retains biocontrol efficiency against fungal phytopathogens in low pH.

Naimisha Chowdhury, Dibya Jyoti Hazarika, Gunajit Goswami, Unmona Sarmah, Shrutirupa Borah, Robin Chandra Boro, Madhumita Barooah

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Naimisha ChowdhuryDBT-North East Centre for Agricultural Biotechnology, Jorhat, Assam, 785013, India.ORCID http://orcid.org/0000-0002-5043-0776
Dibya Jyoti HazarikaDBT-North East Centre for Agricultural Biotechnology, Jorhat, Assam, 785013, India.ORCID http://orcid.org/0000-0001-6370-4230
Gunajit GoswamiDBT-North East Centre for Agricultural Biotechnology, Jorhat, Assam, 785013, India.
Unmona SarmahDBT-North East Centre for Agricultural Biotechnology, Jorhat, Assam, 785013, India.
Shrutirupa BorahDepartment of Agricultural Biotechnology, Assam Agricultural University, Jorhat, Assam, 785013, India.
Robin Chandra BoroDepartment of Agricultural Biotechnology, Assam Agricultural University, Jorhat, Assam, 785013, India.ORCID http://orcid.org/0000-0002-0866-3357
Madhumita BarooahDBT-North East Centre for Agricultural Biotechnology, Jorhat, Assam, 785013, India. m17barooah@yahoo.co.in.ORCID http://orcid.org/0000-0002-3768-5336
North East Institute of Science and Technology · INAssam Agricultural University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Soil pH conditions have important consequences for microbial community structure, their dynamics, ecosystem processes, and interactions with plants. Low soil pH affects the growth and functional activity of bacterial biocontrol agents which may experience a paradigm shift in their ability to act antagonistically against fungal phytopathogens. In this study, the antifungal activity of an acid-tolerant soil bacterium Bacillus amyloliquefaciens MBNC was evaluated under low pH and compared to its activity in neutral pH conditions. Bacterial supernatant from 3-day-old culture (approximately 11.2 × 10

Indexed as

Bacillus amyloliquefaciensAntifungal AgentsEcosystemFungiHydrogen-Ion ConcentrationLipopeptidesPlant DiseasesAntifungal AgentsLipopeptidesAcid stressBacillus amyloliquefaciensBiocontrolHRMSqRT-PCRSurfactin

Identifiers

PMID34997335
OpenAlexW4225596233

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.